<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Cynthia M Chase &#187; Interesting Publications</title>
	<atom:link href="http://www.cynthiamchase.com/category/publications-cynthia-chase-likes/feed" rel="self" type="application/rss+xml" />
	<link>http://www.cynthiamchase.com</link>
	<description></description>
	<lastBuildDate>Thu, 12 Aug 2010 02:48:43 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
		<item>
		<title>1. Nicolson, Garth, Ph.D.&#8221;Diagnosis and therapy of chronic systemic co-infections in Lyme disease and other tick-borne infectious diseases.&#8221;</title>
		<link>http://www.cynthiamchase.com/publications-cynthia-chase-likes/697/1-nicolson-garth-ph-d-diagnosis-and-therapy-of-chronic-systemic-co-infections-in-lyme-disease-and-other-tick-borne-infectious-diseases</link>
		<comments>http://www.cynthiamchase.com/publications-cynthia-chase-likes/697/1-nicolson-garth-ph-d-diagnosis-and-therapy-of-chronic-systemic-co-infections-in-lyme-disease-and-other-tick-borne-infectious-diseases#comments</comments>
		<pubDate>Mon, 09 Aug 2010 16:43:29 +0000</pubDate>
		<dc:creator>Cynthia</dc:creator>
				<category><![CDATA[Interesting Publications]]></category>
		<category><![CDATA[Lyme disease]]></category>

		<guid isPermaLink="false">http://www.cynthiamchase.com/?p=697</guid>
		<description><![CDATA[This article was posted on ConnecticutLyme@yahoogroups.com.  This is very important information so I wanted to send it along to you: &#8220;I recently came back from Corfu, Greece where I was awestruck with its natural, lush terrain and warm- hearted people. A definite must for anyone wanting island sun, blue skies and delightful Mediterranean cuisine. I [...]]]></description>
			<content:encoded><![CDATA[<div><span style="font-family: Arial; font-size: x-small;"><br />
</span></div>
<div></div>
<p><!--~-|**|PrettyHtmlStartT|**|-~--></p>
<div id="ygrp-mlmsg">
<div id="ygrp-msg"><!--~-|**|PrettyHtmlEndT|**|-~--></p>
<div id="ygrp-text">
<p>This article was posted on <a title="blocked::mailto:ConnecticutLyme@yahoogroups.com ConnecticutLyme@yahoogroups.com" href="mailto:ConnecticutLyme@yahoogroups.com">ConnecticutLyme@yahoogroups.com</a>.  This is very important information so I wanted to send it along to you:</p>
<p>&#8220;I recently  came back from Corfu, Greece where I was awestruck with its<br />
natural, lush  terrain and warm- hearted people. A definite must for anyone<br />
wanting island  sun, blue skies and delightful Mediterranean cuisine. I<br />
attended the 18th  American Biologics Symposium. One of the best lectures<br />
given was on the most  recent Lyme disease research by Professor Garth<br />
Nicolson. Here is what I  learned from that presentation:</p>
<p>Lyme disease is a tick-borne illness,  caused by the Borrelia burgdoferi<br />
spirochete. This infection results in  flu-like symptoms, headache and joint<br />
and muscle pain. If the disease is left  untreated and infection spreads,<br />
serious health complications can result.  According to Professor Garth<br />
Nicolson and the Institute of Molecular  Medicine, these chronic conditions,<br />
like fatigue, arthritis, neurological and  heart problems are often mistaken<br />
for other health issues. This can make  treatment difficult if a late-stage<br />
Lyme disease patient is misdiagnosed with  Chronic Fatigue Syndrome or<br />
Rheumatoid Arthritis. Several laboratory tests  need to be conducted to<br />
assure a proper diagnosis.</p>
<p>New research from  The Institute of Molecular Medicine has shown that Lyme<br />
disease is often  accompanied by other infections. The various strains of<br />
the Babesia  protozoan, like Babesia microti, Babesia divergens and Babesia<br />
bova, can  worsen the symptoms of Lyme disease in humans during the early<br />
stages. Some  of these symptoms include weakness, high fever,<br />
gastrointestinal and  respiratory problems, and anemia.</p>
<p>Mycoplasmal infections are very common  with Lyme disease. Research<br />
indicates that 60 to 70% of individuals with Lyme  disease also carry a form<br />
of the Mycoplasma co-infection. It is difficult to  identify Mycoplasmal<br />
infections with lab tests. Mycoplasmas require very  sensitive tests because<br />
they are not detected freely in the blood, but in  various tissues instead.<br />
The symptoms of a Mycoplasmal infection are similar  to the Borrelia<br />
burgdoferi infection.</p>
<p>Various strains of Ehrlichia  are known to cause a co-infection, resulting in<br />
fever, headache, weakness and  pain in the muscles and a low white blood cell<br />
count, among other symptoms.</p>
<p>It is best to treat Lyme disease and the co-infections in its early  stages<br />
before the disease progresses. Those patients with Lyme disease and  any<br />
co-infections can undergo antibiotic treatment. Dietary changes can  help<br />
keep the immune system strong and fight off infection. Diets should  include<br />
whole grains, yogurt, wheat germ, cruciferous vegetables, and fish.  Patients<br />
should avoid junk foods, refined sugars, alcohol and caffeine.  Patients need<br />
to drink plenty of water and juices. It is also important to  take vitamin<br />
and mineral supplements. Levels of vitamin C, E, CoQ-10 and  B-complex are<br />
often poorer in patients with chronic disease due to absorption  problems.<br />
Zinc, magnesium, chromium and selenium stores are often depleted  and can be<br />
restored with supplements.</p>
<p>Overuse of antibiotics destroys  the &#8220;good&#8221; bacteria found in the intestines.<br />
This allows room for dangerous  bacteria to harvest itself in the intestines.<br />
It is recommended that Lyme  disease patients undergoing antibiotic therapy<br />
to add Probiotics to their  diet. Lactobacillus acidophilus, Lactobacillus<br />
bifidus, Lactobacillus  bulgaricus and several other strains can be taken in<br />
a capsule or powder  form. These healthy strains of bacteria replace the<br />
bacteria destroyed by  antibiotics and improve gut health. Herbal remedies<br />
also help to improve the  immune system. Professor Nicolson found that<br />
ginseng root, herbal teas,  bioactive whey protein and olive leaf extract can<br />
help the immune system from  relapsing.</p>
<p>Another herbal remedy for Lyme disease is Uncaria tomentosa,  also known as<br />
&#8220;Cat&#8217;s Claw&#8221;. Cat&#8217;s Claw is found in the product, SamentoR.  Cat&#8217;s Claw<br />
contains pentacyclic oxindale alkaloids (POA&#8217;s), which helps the  immune<br />
system fight infection.</p>
<p>This current research conducted by  Professor Garth Nicolson<br />
and the Institute of Molecular Medicine shows  promising ideas in Lyme<br />
disease. We hope that this research brings about more  advancement in the<br />
field to help those with this disease.</p>
<p>References:</p>
<p>1. Nicolson, Garth, Ph.D.&#8221;Diagnosis and therapy of chronic  systemic<br />
co-infections in Lyme disease and other tick-borne infectious  diseases.&#8221;<br />
&#8220;<a title="blocked::http://www.immed.org/reports/infectious_disease_illness/LYMETreat-01.9.25.h" href="http://www.immed.org/reports/infectious_disease_illness/LYMETreat-01.9.25.h">http://www.immed.org/reports/infectious_disease_illness/LYMETreat-01.9.25.h</a><br />
tml.&#8221;</p>
<p>_____<br />
For more  information visit</p>
</div>
<p><!--~-|**|PrettyHtmlStart|**|-~--></p>
<div id="ygrp-grfd"><a title="blocked::http://www.lymedisease.com/" href="http://www.lymedisease.com/">http://www.lymedisease.com</a><br />
<!-- |**|end egp html banner|**| --></div>
<div id="ft"><a title="blocked::http://groups.yahoo.com/;_ylc=X3oDMTJlbmxqYWZyBF9TAzk3MzU5NzE0BGdycElkAzE4MTczODk5BGdycHNwSWQDMTcwNTA2MTQ5OARzZWMDZnRyBHNsawNnZnAEc3RpbWUDMTI4MTMwMDIzMg--" href="http://groups.yahoo.com/;_ylc=X3oDMTJlbmxqYWZyBF9TAzk3MzU5NzE0BGdycElkAzE4MTczODk5BGdycHNwSWQDMTcwNTA2MTQ5OARzZWMDZnRyBHNsawNnZnAEc3RpbWUDMTI4MTMwMDIzMg--"><br />
</a></div>
<p><!-- |**|end egp html banner|**| --></div>
<p><!-- ygrp-msg --><!-- Sponsor --><!-- |**|begin egp html banner|**| --></p>
<div id="ygrp-sponsor"><!-- Start Recommendations --> <!-- End Recommendations --></div>
<p><!-- |**|end egp html banner|**| --></div>
<p><img src="http://geo.yahoo.com/serv?s=97359714/grpId=18173899/grpspId=1705061498/msgId=2620/stime=1281300232/nc1=1/nc2=2/nc3=3" alt="Right-click here to download pictures. To help protect your privacy, Outlook prevented automatic download of this picture from the Internet." width="1" height="1" /></p>
<div></div>
<p><!--~-|**|PrettyHtmlEnd|**|-~--><!--~-|**|PrettyHtmlStart|**|-~--> <!-- #ygrp-mkp { 	BORDER-BOTTOM: #d8d8d8 1px solid; BORDER-LEFT: #d8d8d8 1px solid; PADDING-BOTTOM: 0px; MARGIN: 10px 0px; PADDING-LEFT: 10px; PADDING-RIGHT: 10px; FONT-FAMILY: Arial; BORDER-TOP: #d8d8d8 1px solid; BORDER-RIGHT: #d8d8d8 1px solid; PADDING-TOP: 0px } #ygrp-mkp HR { 	BORDER-BOTTOM: #d8d8d8 1px solid; BORDER-LEFT: #d8d8d8 1px solid; BORDER-TOP: #d8d8d8 1px solid; BORDER-RIGHT: #d8d8d8 1px solid } #ygrp-mkp #hd { 	LINE-HEIGHT: 122%; MARGIN: 10px 0px; COLOR: #628c2a; FONT-SIZE: 85%; FONT-WEIGHT: 700 } #ygrp-mkp #ads { 	MARGIN-BOTTOM: 10px } #ygrp-mkp .ad { 	PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px } #ygrp-mkp .ad A { 	COLOR: #0000ff; TEXT-DECORATION: none } #ygrp-sponsor #ygrp-lc { 	FONT-FAMILY: Arial } #ygrp-sponsor #ygrp-lc #hd { 	LINE-HEIGHT: 122%; MARGIN: 10px 0px; FONT-SIZE: 78%; FONT-WEIGHT: 700 } #ygrp-sponsor #ygrp-lc .ad { 	PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; MARGIN-BOTTOM: 10px; PADDING-TOP: 0px } A { 	COLOR: #1e66ae } #actions { 	PADDING-BOTTOM: 10px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-FAMILY: Verdana; FONT-SIZE: 11px; PADDING-TOP: 10px } #activity { 	PADDING-BOTTOM: 10px; BACKGROUND-COLOR: #e0ecee; PADDING-LEFT: 10px; PADDING-RIGHT: 10px; FONT-FAMILY: Verdana; FLOAT: left; FONT-SIZE: 10px; PADDING-TOP: 10px } #activity SPAN { 	FONT-WEIGHT: 700 } #activity SPAN:first-child { 	TEXT-TRANSFORM: uppercase } #activity SPAN A { 	COLOR: #5085b6; TEXT-DECORATION: none } #activity SPAN SPAN { 	COLOR: #ff7900 } #activity SPAN .underline { 	TEXT-DECORATION: underline } .attach { 	PADDING-BOTTOM: 10px; PADDING-LEFT: 0px; WIDTH: 400px; PADDING-RIGHT: 0px; DISPLAY: table; FONT-FAMILY: Arial; CLEAR: both; FONT-SIZE: 12px; PADDING-TOP: 10px } .attach DIV A { 	TEXT-DECORATION: none } .attach IMG { 	BORDER-BOTTOM-STYLE: none; BORDER-RIGHT-STYLE: none; PADDING-RIGHT: 5px; BORDER-TOP-STYLE: none; BORDER-LEFT-STYLE: none } .attach LABEL { 	DISPLAY: block; MARGIN-BOTTOM: 5px } .attach LABEL A { 	TEXT-DECORATION: none } BLOCKQUOTE { 	MARGIN: 0px 0px 0px 4px } .bold { 	FONT-FAMILY: Arial; FONT-SIZE: 13px; FONT-WEIGHT: 700 } .bold A { 	TEXT-DECORATION: none } DD.last P A { 	FONT-FAMILY: Verdana; FONT-WEIGHT: 700 } DD.last P SPAN { 	FONT-FAMILY: Verdana; FONT-WEIGHT: 700; MARGIN-RIGHT: 10px } DD.last P SPAN.yshortcuts { 	MARGIN-RIGHT: 0px } DIV.attach-table DIV DIV A { 	TEXT-DECORATION: none } DIV.attach-table { 	WIDTH: 400px } DIV.file-title A { 	TEXT-DECORATION: none } DIV.file-title A:active { 	TEXT-DECORATION: none } DIV.file-title A:hover { 	TEXT-DECORATION: none } DIV.file-title A:visited { 	TEXT-DECORATION: none } DIV.photo-title A { 	TEXT-DECORATION: none } DIV.photo-title A:active { 	TEXT-DECORATION: none } DIV.photo-title A:hover { 	TEXT-DECORATION: none } DIV.photo-title A:visited { 	TEXT-DECORATION: none } DIV#ygrp-mlmsg #ygrp-msg P A SPAN.yshortcuts { 	FONT-FAMILY: Verdana; FONT-SIZE: 10px; FONT-WEIGHT: normal } .green { 	COLOR: #628c2a } .MsoNormal { 	MARGIN: 0px } o { 	FONT-SIZE: 0px } #photos DIV { 	WIDTH: 72px; FLOAT: left } #photos DIV DIV { 	BORDER-BOTTOM: #666666 1px solid; BORDER-LEFT: #666666 1px solid; WIDTH: 62px; HEIGHT: 62px; OVERFLOW: hidden; BORDER-TOP: #666666 1px solid; BORDER-RIGHT: #666666 1px solid } #photos DIV LABEL { 	TEXT-ALIGN: center; WIDTH: 64px; WHITE-SPACE: nowrap; COLOR: #666666; FONT-SIZE: 10px; OVERFLOW: hidden } #reco-category { 	FONT-SIZE: 77% } #reco-desc { 	FONT-SIZE: 77% } .replbq { 	MARGIN: 4px } #ygrp-actbar DIV A:first-child { 	PADDING-RIGHT: 5px; MARGIN-RIGHT: 2px } #ygrp-mlmsg { 	FONT-FAMILY: Arial, helvetica,clean, sans-serif; FONT-SIZE: small } #ygrp-mlmsg TABLE { 	 } #ygrp-mlmsg SELECT { 	FONT: 99% Arial, Helvetica, clean, sans-serif } INPUT { 	FONT: 99% Arial, Helvetica, clean, sans-serif } TEXTAREA { 	FONT: 99% Arial, Helvetica, clean, sans-serif } #ygrp-mlmsg PRE { 	FONT: 100% monospace } CODE { 	FONT: 100% monospace } #ygrp-mlmsg * { 	LINE-HEIGHT: 1.22em } #ygrp-mlmsg #logo { 	PADDING-BOTTOM: 10px } #ygrp-mlmsg A { 	COLOR: #1e66ae } #ygrp-msg P A { 	FONT-FAMILY: Verdana } #ygrp-msg P#attach-count SPAN { 	COLOR: #1e66ae; FONT-WEIGHT: 700 } #ygrp-reco #reco-head { 	COLOR: #ff7900; FONT-WEIGHT: 700 } #ygrp-reco { 	PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; MARGIN-BOTTOM: 20px; PADDING-TOP: 0px } #ygrp-sponsor #ov LI A { 	FONT-SIZE: 130%; TEXT-DECORATION: none } #ygrp-sponsor #ov LI { 	PADDING-BOTTOM: 6px; LIST-STYLE-TYPE: square; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; FONT-SIZE: 77%; PADDING-TOP: 6px } #ygrp-sponsor #ov UL { 	PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-LEFT: 8px; PADDING-RIGHT: 0px; PADDING-TOP: 0px } #ygrp-text { 	FONT-FAMILY: Georgia } #ygrp-text P { 	MARGIN: 0px 0px 1em } #ygrp-text TT { 	FONT-SIZE: 120% } #ygrp-vital UL LI:unknown { 	BORDER-RIGHT-STYLE: none !important } --> <!--~-|**|PrettyHtmlEnd|**|-~--><!-- end group email --></p>
]]></content:encoded>
			<wfw:commentRss>http://www.cynthiamchase.com/publications-cynthia-chase-likes/697/1-nicolson-garth-ph-d-diagnosis-and-therapy-of-chronic-systemic-co-infections-in-lyme-disease-and-other-tick-borne-infectious-diseases/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NIH proposes new funding rules to prevent conflicts of interest</title>
		<link>http://www.cynthiamchase.com/publications-cynthia-chase-likes/663/nih-proposes-new-funding-rules-to-prevent-conflicts-of-interest</link>
		<comments>http://www.cynthiamchase.com/publications-cynthia-chase-likes/663/nih-proposes-new-funding-rules-to-prevent-conflicts-of-interest#comments</comments>
		<pubDate>Mon, 24 May 2010 18:11:42 +0000</pubDate>
		<dc:creator>Cynthia</dc:creator>
				<category><![CDATA[Interesting Publications]]></category>
		<category><![CDATA[Lyme disease]]></category>

		<guid isPermaLink="false">http://www.cynthiamchase.com/?p=663</guid>
		<description><![CDATA[http://www.washingtonpost.com/wp-dyn/content/article/2010/05/20/AR2010052003038.html NIH proposes new funding rules to prevent conflicts of interest By Rob Stein Friday, May 21, 2010; A16 The National Institutes of Health proposed new guidelines Thursday to prevent financial conflicts of interest among thousands of researchers who receive federal funding, a move long sought by watchdogs of scientific research concerned about the influence [...]]]></description>
			<content:encoded><![CDATA[<p><span><a title="blocked::http://www.washingtonpost.com/wp-dyn/content/article/2010/05/20/AR2010052003038.html" href="http://www.washingtonpost.com/wp-dyn/content/article/2010/05/20/AR2010052003038.html">http://www.washingtonpost.com/wp-dyn/content/article/2010/05/20/AR2010052003038.html</a></p>
<p>NIH proposes new funding rules to prevent conflicts of  interest</p>
<p>By Rob Stein<br />
Friday, May 21, 2010; A16</p>
<p>The National  Institutes of Health proposed new guidelines Thursday to prevent financial  conflicts of interest among thousands of researchers who receive federal  funding, a move long sought by watchdogs of scientific research concerned about  the influence of the drug industry and others.</p>
<p>The move, which will  affect more than 40,000 researchers, comes amid rising concern about the  influence of the pharmaceutical industry and other private-sector interests on  scientific research. In a series of high-profile cases, federally funded  researchers have received upward of millions of dollars from companies with a  financial interest in the outcome of their work.</p>
<p>Among other changes,  the new guidelines will reduce from $10,000 to $5,000 the minimum payment that  researchers will be required to report and mandate that universities, colleges,  research institutes, businesses and other entities that employ researchers who  receive NIH funding monitor compliance with the new reporting requirement.  Funding information would have to be posted on a publicly accessible Web site.  Violators could lose their funding.</p>
<p>&#8220;Partnerships between NIH-funded  researchers and industry are essential. They have been, and they will be,&#8221; NIH  Director Francis S. Collins said in announcing the guidelines, which will be  subject to 60 days of public comment and possible revision before becoming  final. &#8220;At the same time, we need to be clear that in order to preserve the  public trust in the objectivity of biomedical and behavioral research, all  research has to be conducted without bias and with the highest scientific and  ethical standards.&#8221;</p>
<p>Collins stressed that, in most cases, the integrity  of scientific research has not been compromised by outside funding. But even the  appearance of a conflict can undermine public trust, he said.</p>
<p>&#8220;The  public trust in what we do is just essential, and we cannot afford to take any  chances with the integrity of the research process,&#8221; Collins said.</p>
<p>Universities and professional organizations have been tightening their  policies concerning outside funding in recent years to prevent conflicts of  interests. The National Academy of Sciences&#8217; Institute of Medicine released a  scathing report last year urging doctors to stop accepting money, gifts and free  drug samples from drug and medical device companies.</p>
<p>Sen. Charles E.  Grassley (R-Iowa), who has been investigating conflicts of interest in federally  funded research, welcomed the proposed changes, which he said he planned to  review.</p>
<p>&#8220;Disclosure of financial relationships and the resulting  accountability have been sorely lacking in federally sponsored research,&#8221;  Grassley said in a statement. &#8220;Letting the sun shine in and making information  public is basic to building people&#8217;s confidence in medicine. And with the  taxpayer funding that&#8217;s involved, people have a right to know. Public trust and  public dollars are at stake.&#8221;</p>
<p>Several groups that had been advocating  for tougher rules praised the proposal.</p>
<p>&#8220;The leaders of the NIH are  finally considering seriously an idea they have rejected for years: public  disclosure of grantees&#8217; financial arrangements that may create conflicts of  interest,&#8221; said Ned Feder of the Project on Government Oversight.</p>
<p>Allan  Coukell, director of the Pew Prescription Project, a consumer advocacy group,  said the rules were a step in the right direction, though there were some  shortcomings. The rules should require researchers to report any financial  interest, even those less than $5,000, he said. The rules also do not require  those receiving more than $250,000 to specify the amount any further.</p>
<p>&#8220;From the public&#8217;s point of view of trying to assess someone&#8217;s financial  stake, you&#8217;ll have no way of knowing whether they have a $250,000 interest or a  $1 million interest,&#8221; Coukell said.</p>
<p>A spokesman for PhRMA, which  represents the pharmaceutical industry, said the group was reviewing the  proposed rules. </span></p>
]]></content:encoded>
			<wfw:commentRss>http://www.cynthiamchase.com/publications-cynthia-chase-likes/663/nih-proposes-new-funding-rules-to-prevent-conflicts-of-interest/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Genetic testing for Depression?</title>
		<link>http://www.cynthiamchase.com/faq/638/genetic-testing-for-depression</link>
		<comments>http://www.cynthiamchase.com/faq/638/genetic-testing-for-depression#comments</comments>
		<pubDate>Tue, 18 May 2010 02:33:39 +0000</pubDate>
		<dc:creator>Cynthia</dc:creator>
				<category><![CDATA[Frequently Asked Questions]]></category>
		<category><![CDATA[Interesting Publications]]></category>
		<category><![CDATA[Lyme disease]]></category>
		<category><![CDATA[Thoughts on Therapy]]></category>
		<category><![CDATA[Epi-genetics: hope through understanding]]></category>
		<category><![CDATA[The secret treatment for intractable depression]]></category>

		<guid isPermaLink="false">http://www.cynthiamchase.com/?p=638</guid>
		<description><![CDATA[Well, I find it very interesting that we may be on our way to understanding depression from a different perspective &#8211; especially for those who have been on antidepressants and have not found lasting effective treatment.  This new knowledge has led to a natural vitamin treatment without side effects! GENERAL INFORMATION ABOUT THE GENETIC TEST [...]]]></description>
			<content:encoded><![CDATA[<p>Well, I find it very interesting that we may be on our way to understanding depression from a different perspective &#8211; especially for those who have been on antidepressants and have not found lasting effective treatment.  This new knowledge has led to a natural vitamin treatment without side effects!</p>
<p><strong>GENERAL INFORMATION ABOUT THE GENETIC TEST</strong></p>
<p>The genetic test &#8211; which can be done from a simple blood draw- is called the <strong>MTHFR test</strong>.  The official name of this gene is &#8220;5,10-methylenetetrahydrofolate reductase&#8221; (NADPH).  MTHFR is the gene&#8217;s official shorthand symbol &#8211; and now you know why!  Just for an interesting clarification, the gene is located on the short (p) arm of chromosome 1 at position 36.3.</p>
<p>The normal function of this gene provides instructions for making an enzyme called <strong>methylenetetrahydrofolate reductase</strong>.  This hormone plays a key role in processing amino acids, the building blocks of proteins.  If a mutation occurs in the MTHFR gene, folate/B vitamins may not be broken down in such a way that the body can utilize them.</p>
<p>(Let it be known that this research and information is very difficult to understand and translate; in fact, it is nearly indecipherable to this lay person!  I have struggled with it and the following is hard won information which I hope will help you to understand this complex and emerging field.)</p>
<p>From a review of some of the literature and research on the <strong>MTHFR genetic abnormality</strong>, mutations of this gene may be implicated with the following:</p>
<ul>
<li><strong>elevated homocystiene levels (a potentially toxic amino acid) leading to heart problems</strong></li>
<li><strong>venous thrombosis</strong></li>
<li><strong> blood clotting issues</strong></li>
<li><strong>certain types of severe birth defects (for example, neural tube defects)</strong></li>
<li><strong>miscarriages</strong></li>
<li><strong>high blood pressure in pregnancy</strong></li>
<li><strong>coronary heart disease and stroke</strong></li>
<li><strong> mental illness, most often connected with depression and possibly schizophrenia</strong></li>
</ul>
<p><strong>Researchers from all over the world are publishing studies searching for additional connections; a lot more information is on the way</strong></p>
<p><strong>Depression</strong></p>
<p>In reference to my focus on mental health, The Hordaland Homocysteine Study is the one most quoted for their research connecting the MTHFR 677C-T mutation with difficulty metabolizing folate and B12; this leads to issues of elevated homocysteine, anxiety and depression.   Another important study is entitled:   &#8220;The Thermolabile variant of the MTHFR is associated with depression in the British Women&#8217;s Heart and Health Study and a meta-analysis.&#8221;</p>
<p>Both of these studies suggest that due to the body&#8217;s inability to metabolize folate/ B- 12  there is a greater risk of depression.  Here is how it appears to work:</p>
<ul>
<li>Depressive symptoms may be linked to insufficient neurotransmitters or  imbalance of one or more of the three neurotransmitters:</li>
</ul>
<ol>
<li><strong>Serotonin </strong>(linked to obsessions and compulsions and memory)</li>
<li><strong>Nor-epinephrine </strong>(linked to alertness, concentration and energy)</li>
<li><strong>Dopamine</strong> (linked to pleasure, reward, motivation and drive)</li>
</ol>
<ul>
<li>When these <strong>three neurotransmitters are in sufficient quantity and in balance</strong>, anxiety is reduced, impulse control and irritability is minimized, there is a capacity for positive mood and good cognitive function, attention can be maintained, and appetite is in normalized.  There is also normalized sexual drive and reduced aggression.</li>
</ul>
<ul>
<li>Your doctor or other health care provider may prescribe  antidepressants to treat the imbalance of these neurotransmitters.  However, what we have come to see is that a significant portion of the population that does not respond successfully to antidepressants.</li>
</ul>
<ul>
<li>This research may point to the reason for ineffective treatment of depression by antidepressants alone.  <strong>The theory here is that the brain may not be producing enough neurotransmitters due to insufficient amounts of L-methylfolate in the brain</strong>.  L-methylfolate is needed to regulate serotonin, nor-epinephrine and dopamine production.   <strong>Without enough L-methylfolate it may be difficult for the brain to produce enough neurotransmitters for the antidepressant to work fully.</strong></li>
</ul>
<ul>
<li><strong>An abnormality in the MTHFR gene prevents the breakdown of folate/B vitamins; as a result, the neurotransmitter building blocks are not available for health brain function.</strong> <strong> By taking an activated, or metabolized form of folate/B vitamins the body is then able to produce sufficient neurotransmitters .</strong> This alone may improve functioning for some;  for others, by combining the activated form of folate/B12 with antidepressants, improved results follow.</li>
</ul>
<ul>
<li> 70 percent of those with a diagnosis of depression may have a specific genetic factor that limits their ability to convert folic acid or folate from food or supplements to L-methylfolate.</li>
</ul>
<ul>
<li>The prescription Deplin is actually L-methylfolate in an active, metabolized form that can cross the blood brain barrier to help the brain regulate these important neurotransmitters associated with mood.  This is a prescription item only, and  is not available in drug or health food stores off the shelf.</li>
</ul>
<ul>
<li>There are no side effects with this product (as reported by the company that produces Deplin); patient surveys have shown 86 percent symptom improvement.</li>
</ul>
<p>Test results show that if there is a positive genetic mutation  it may be what is called homozygous or heterozygous.  Here is a more detailed explanation of the definition of these terms.    These definitions are taken from http://medical-dictionary.thefreedictionary.com:</p>
<ul>
<li><strong>Two copies:  Homozygous</strong></li>
</ul>
<div>[hō′məzī′gəs]</p>
<div>Etymology:  Gk, <em>homos</em> + <em>zygon,</em> yoke</div>
<div><strong>Identical genes controlling a specified inherited  trait.</strong></div>
</div>
<div>
<div>&#8220;having two identical alleles at corresponding loci on   homologous chromosomes.<strong> An individual who is homozygous for a trait has   inherited from each parent one allele for that trait.</strong> A person who is   homozygous for a genetic disease caused by a pair of recessive alleles,   such as sickle cell anemia, manifests the disorder. All of his or her   offspring will inherit the allele for the disease.&#8221;</div>
</div>
<ul>
<li><strong>One copy:</strong> <strong>heterozygous </strong></li>
</ul>
<div>[het′ərəzī′gəs]</p>
<div>Etymology:  Gk, <em>heteros</em> + <em>zygotos,</em> yoked</div>
<div><strong>Two different genes controlling a specified inherited trait.</strong></div>
</div>
<p>&#8220;having two different alleles at corresponding loci on  homologous chromosomes.<strong> An individual who is heterozygous for a trait  has inherited an allele for that trait from one parent and an  alternative allele from the other parent</strong>. An individual who is  heterozygous for a genetic disease caused by a dominant allele, such as  Huntington&#8217;s disease, manifests the disorder. A person who is  heterozygous for a hereditary disorder produced by a recessive allele,  such as sickle cell anemia, is asymptomatic or exhibits reduced symptoms  of the disease. The offspring of a heterozygous carrier of a genetic  disorder have a 50% chance of inheriting the allele associated with the  disorder if the other parent does not carry the allele.&#8221;</p>
<p>(While this level of detail is not easily understood, I wanted to insert it here since this is the language that geneticists use in sharing the results of the genetic tests administered.)</p>
<p><strong>What all this complex information means is that it is now possible to effect positive emotional changes by identifying these genetic abnormalities and adding to the treatment regimen an activated (metabolized) B vitamin, thereby aiding in the production of neurotransmitters, which are the basis for health brain function.  These are the potential benefits to this protocol:</strong></p>
<ul>
<li><strong>motivation</strong></li>
<li><strong>alertness</strong></li>
<li><strong>initiative</strong></li>
<li><strong>concentration</strong></li>
<li><strong>improved mood</strong></li>
<li><strong>sociability</strong></li>
</ul>
<p><strong>This is new information and much more research is needed to understand how the genetic mutations of the MTHFR gene affect us; what is exciting is that the introduction of a natural vitamin may provide the key to improved mental health in over 70% of people with depression.</strong></p>
<p><strong>Does genetics determine our fate?  Not necessarily.  Some genetic predispositions can be altered by understanding and altering our diet and lifestyle. This is called Epi-Genetics!  Above and beyond genetics.   Welcome to the new world.<br />
</strong></p>
<p>I will keep you posted as I gain more knowledge of this critically important emerging field.</p>
<p>Cynthia</p>
]]></content:encoded>
			<wfw:commentRss>http://www.cynthiamchase.com/faq/638/genetic-testing-for-depression/feed</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Dr. Dietrick Klinghardt, MD, PhD takes the lead in developing a Unified Theory of Disease</title>
		<link>http://www.cynthiamchase.com/reiki-fusion/450/dr-dietrick-klinghardt-md-phd-takes-the-lead-in-developing-a-unified-theory-of-lyme-disease</link>
		<comments>http://www.cynthiamchase.com/reiki-fusion/450/dr-dietrick-klinghardt-md-phd-takes-the-lead-in-developing-a-unified-theory-of-lyme-disease#comments</comments>
		<pubDate>Mon, 28 Dec 2009 23:40:53 +0000</pubDate>
		<dc:creator>Cynthia</dc:creator>
				<category><![CDATA[Interesting Publications]]></category>
		<category><![CDATA[Lyme disease]]></category>
		<category><![CDATA[REIKI FUSION]]></category>

		<guid isPermaLink="false">http://www.cynthiamchase.com/?p=450</guid>
		<description><![CDATA[I have been researching the work of Dietrict Klinghardt, MD, PhD, for months now, seeking to understand his overall approach and underlying assumptions.  He has been synthesizing traditional and alternative medicine for over 30 years.  He has studied medicine, psychology and spirituality with an over-reaching high level of integrative intelligence .  He has studied the [...]]]></description>
			<content:encoded><![CDATA[<p>I have been researching the work of <strong>Dietrict Klinghardt, MD, PhD,</strong> for months now, seeking to understand his overall approach and underlying assumptions.  He has been synthesizing traditional and alternative medicine for over 30 years.  He has studied medicine, psychology and spirituality with an over-reaching high level of integrative intelligence .  He has studied the effect of heavy metals, environmental pollutants and electromagnetic effects on the human body. He seeks to understand the underlying factors of dis-ease and share his wisdom with us all.  His work is comprehensive, broad-reaching and at times, erudite.</p>
<p>Dr. Klinghardt is a <strong>neurobiologist, an integrative physician and is a leading proponant of holistic treatment</strong>. He studies the nervous system in an interdisciplinary way that involves other disciplines such as psychology, computer science, statistics, physics, philosophy and medicine.    He is a fierce advocate for patient self-care; he publishes and teaches his approach in America and Europe to educate us about prevention and natural treatments  so that we all have access to the means of cleansing, balancing and healing ourselves.   His work is , in many respects, consistent with other naturopathic physicians in that he seeks to assist the human body to function optimally through the use of <strong>herbs, homeopathic medicine and lifestyle changes</strong>.  He has added an <strong>energy medicine</strong> component for both diagnosis and treatment and is in the forefront in proposing this ancient, and at the same time, newest and most promising approach to healing.</p>
<p>The foundation of his approach is based on his understanding of the<strong> five levels of healing.</strong> While in India about 30 years ago he went to a lecture given by a Guru (wise man) who talked about an ancient  (12,000 years old) Tibetan philosophy based on an understanding of humans as beings comprised of five different levels:<strong> the physical, the electromagnetic, the mental, the intuitive body, and the spirit body</strong>.  All but the physical are invisible to the human eye, although some people can &#8220;see&#8221;, feel or sense fields of energy relating to the other, usually invisible aspects.</p>
<p>The premise that is most fascinating for our purposes is that<strong> in order to be well, all levels of the human being must be healed</strong>.  This is so because the physical aspect of us is the materiel manifestation of all the other components.  The other four layers interpenetrate with the physical and affect the health of the physical being.</p>
<p>Let&#8217;s reference each of these layers and briefly touch on how each of these layers relate to illness.  Let&#8217;s say that a person has been diagnosed with Lyme disease.  On a <strong>physical level</strong> it means that bacterial organisms are multiplying in the body, moving to different parts of the body, generating neuro-toxins which cause symptoms in their own right.  It may be that the physical body has been diagnosed with heavy metal toxicity, for example, mercury, and that the toxins need to be cleared so that the body may more effectively fight it&#8217;s battle against the bacterial invaders.  This is the world of orthomolecular and allopathic medicine.  On this level antibiotics may be prescribed to kill off the unwanted organisms, detoxifying herbs given for clearing out the neuro-toxins and by-products of the die-off.</p>
<p>On the <strong>second level</strong>, the <strong>electromagnetic level, </strong>it may be seen that the patient has developed an inflammatory response (physical level) that produces inflamed, painful energy in response to the direct effect of the bacteria, or the by-products of their living and dying. This energy may be present in the physical mass of muscles, joints,or organs.  Since pain causes us to contract, resist or avoid, that energy may become stuck or constricted.  Within this model, healing energy work, such as<strong> Reiki, Hands on Healing, acupuncture, reflexology, or (in Dietrict Klinghart&#8217;s lexicon) Autonomic Response</strong> testing may be used.  Through the movement and clearing out of painful, inflamed energy the void is then filled with the natural life force within all human beings; it then has a chance to flow and heal.  Note:  according to this model, the layers below (in this case the physical) are affected positively.</p>
<p>On <strong>the third level</strong>, <strong>the mental body</strong>, unresolved emotional conflict creates a disturbance in (what is known in neuroscience as) the <strong>bio-photon field </strong>which surrounds the body, and is generated by the DNA.</p>
<p>Neuro-science tells us that short term memory is tracked in brain circuitry (first level); according to this way of understanding the human, long term and extrasensory perceptions reside in the energy field that surrounds the body- the physical brain is seen as a &#8220;tuner&#8221; for memory storage. <strong><strong> </strong></strong></p>
<p><strong>Fritz-Albert Popp, a German physicist</strong> pioneered research about the vibrational nature of our cells, and is reported to have confirmed the existence of biophotons which emit tiny quantities of light.  We are beginning to understand how these invisible entities communicate complex information and orchestrate metabolic function.  For details about this go to mercola.com to see an interview of Klinghardt on the subject &#8211; fascinating!)</p>
<p>If this Lyme disease patient were to enter into psychotherapy there may be found traumatic, unresolved issues in their own life history, or in the family history that may have been passed on.  This unresolved history is held in the field of energy that surrounds the physical body.  By facing and resolving this (conscious, unconscious or sub-conscious) pain, that then allows a flow and healing of the energy body that would otherwise weigh down or inhibit full healing.</p>
<p>The <strong>forth level</strong> of healing is identified as <strong>the Intuitive body</strong>.  It is realm of the shaman, the religious, the spiritual, and your metaphysical experiences.  Dr. Klinghardt postulates that on this level unresolved conflict and trauma from a person&#8217;s past and from their history can generate physical illness.  Unless these traumas are faced and resolved, they may act out these unresolved issues in spite of a medical approach dealing only with the physical body.</p>
<p>So for our purposes, with this same Lyme disease patient, if this person, for example, had parents or grandparents who were sexually or physically abused, the unresolved trauma may be carried on the the person&#8217;s memory/field of energy;  unless faced, mourned and the associated feelings of anger, rage and despair are released, the effects of the trauma are played out in the present.  Klinghardt developed something he calls <strong>Family Constellation work</strong> to delve into the family history and therapeutically identify and resolve the trauma.</p>
<p>Our Lyme patient may receive the best treatment for the physical components of Lyme disease, but, according to this model, the patient will be vulnerable to continued illness unless this &#8220;contaminating&#8221; emotional disability is healed through psychotherapy, family therapy or other uncovering and healing teahniques.</p>
<p>The <strong>fifth level of healing, the individual&#8217;s connection to the divine, </strong>is deeply personal, and is the most important and largest part of the human being.  This is the level of self-healing and relates to the &#8220;highest self&#8221;.</p>
<p>Klinghardt&#8217;s premise is that illness can originate on any of the four lower levels and <strong>unless the source of the illness is healed disease will be resistant to healing, or it may transform into another form of disease</strong>.  Illness that is treated symptomatically but that does not treat the actual cause of the illness is short-sited and will likely be unsuccessful.</p>
<p>This concludes my summary of Dr. Klinghardt&#8217;s work.  I hope you have found it as stimulating and as interesting as I have.  Please let me know what your thoughts are, and send along any questions you may have!</p>
<p>Cynthia</p>
]]></content:encoded>
			<wfw:commentRss>http://www.cynthiamchase.com/reiki-fusion/450/dr-dietrick-klinghardt-md-phd-takes-the-lead-in-developing-a-unified-theory-of-lyme-disease/feed</wfw:commentRss>
		<slash:comments>11</slash:comments>
		</item>
		<item>
		<title>Review: CUTTING EDGE RESEARCH BY EVA SAPI, PH.D</title>
		<link>http://www.cynthiamchase.com/publications-cynthia-chase-likes/499/review-cutting-edge-research-by-eva-sapi-ph-d</link>
		<comments>http://www.cynthiamchase.com/publications-cynthia-chase-likes/499/review-cutting-edge-research-by-eva-sapi-ph-d#comments</comments>
		<pubDate>Wed, 29 Jul 2009 01:46:44 +0000</pubDate>
		<dc:creator>Cynthia</dc:creator>
				<category><![CDATA[Interesting Publications]]></category>
		<category><![CDATA[Lyme disease]]></category>
		<category><![CDATA[biofilm]]></category>
		<category><![CDATA[BORRELLIA BURGDORFERI]]></category>
		<category><![CDATA[Dr.Eva Sapi]]></category>

		<guid isPermaLink="false">http://www.cynthiamchase.com/?p=499</guid>
		<description><![CDATA[BIOFILM:  A NEW HIDEOUT FOR BORRELLIA BURGDORFERI It is as though Dr.Eva Sapi is on a Safari in the deepest jungle in Africa.  She is mapping out a totally unknown area of the world filled with dangerous animals, new forms of life never seen by man (or woman) and she is armed only with her [...]]]></description>
			<content:encoded><![CDATA[<p><strong>BIOFILM:  A NEW HIDEOUT FOR BORRELLIA BURGDORFERI</strong></p>
<p>It is as though <strong>Dr.Eva Sapi</strong> is on a Safari in the deepest jungle in Africa.  She is mapping out a totally unknown area of the world filled with dangerous animals, new forms of life never seen by man (or woman) and she is armed only with her microscope.  She is in this reality Eva Sapi, Ph.D., assistant professor of cellular and molecular biology at the University of New Haven, Connecticut.  Her brand new article in the Lyme Times summarizes her research on an entity called <strong>biofilm</strong>.  A rather dry word, but an amazing concept.  For those of us lay persons interested in Lyme disease and co-infections and why it appears that some people have chronic infection the concept is revolutionary in its possibilities.</p>
<p>Here is how it works:  the research shows that when enough microbes gather they begin to adhere to each other or to living or inert surfaces.  These organisms then communicate to each other and start a change in &#8220;gene expression&#8221; that allows the cells to produce something called &#8220;exopolysaccharide&#8221; which becomes a &#8220;<strong>protective matrix</strong>&#8220;.</p>
<p>Like a moat which surrounds the castle it provides protection from attacking forces &#8211; like phagocytes or antibacterial agents!  Not only that, German scientists  using  marine bacteria identified that this biofilm actually is capable of  releasing a paralyzing agent.  &#8220;It appears that biofilm is not just a defensive fortress, it can also fight back.&#8221;</p>
<p>Dr. Sapi in conjunction with Dr. Alan MacDonald has recently worked &#8220;in vitro&#8221; to study biofilm formation of Borrelia burgdorferi.<strong> In her words:  &#8220;In summary, if we can demonstrate that biofilm structure of Borrelia burgdorferi renders them resistant to antibiotics, it could provide a logical explanation as to why extensive antibiotic treatment for patients with a tick-bite history could fail.  The end result from our study could provide novel therapeutic approaches for Lyme literate physicians to explore for chronically ill patients&#8221;</strong></p>
<p>Please go to <strong>lymetimes.org</strong> for the above-reviewed article in its entirety and join to receive the most up-to-date research and support.</p>
<p>Cynthia</p>
]]></content:encoded>
			<wfw:commentRss>http://www.cynthiamchase.com/publications-cynthia-chase-likes/499/review-cutting-edge-research-by-eva-sapi-ph-d/feed</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Lyme in the News &#8211; Good News</title>
		<link>http://www.cynthiamchase.com/publications-cynthia-chase-likes/428/lyme-in-the-news-good-news</link>
		<comments>http://www.cynthiamchase.com/publications-cynthia-chase-likes/428/lyme-in-the-news-good-news#comments</comments>
		<pubDate>Mon, 30 Mar 2009 17:57:51 +0000</pubDate>
		<dc:creator>Cynthia</dc:creator>
				<category><![CDATA[Interesting Publications]]></category>
		<category><![CDATA[Lyme disease]]></category>
		<category><![CDATA[Lyme News]]></category>

		<guid isPermaLink="false">http://www.cynthiamchase.com/?p=428</guid>
		<description><![CDATA[- The Legislature's Public Health Committee unanimously passed a
bill about tick-borne Lyme disease Thursday that could rock the health care
industry if it becomes law.]]></description>
			<content:encoded><![CDATA[<div><span style="font-family: Arial; font-size: x-small;"><!--~-|**|PrettyHtmlStartT|**|-~--><span style="font-family: Times New Roman; font-size: small;"> </span></p>
<div id="ygrp-mlmsg" style="width: 300px; position: relative;">
<div id="ygrp-msg" style="margin: 0px; padding: 0px 25px 0px 0px; z-index: 1; float: left; width: 470px;"><!--~-|**|PrettyHtmlEndT|**|-~--></p>
<div id="ygrp-text">
<p>Update:  More good news</p>
<p><span>CT Doctor Protection Bill Passes House</span></p>
<p>April 30, 2009- Connecticut  Lyme groups and the national Lyme Disease<br />
Association, Inc. are pleased to  announce that H.B. 6200, with a floor<br />
amendment by Representative Betsy  Ritter et al., passed through the<br />
Connecticut House of Representatives.</p>
<p>The House vote was unanimously in support of the bill by a final vote of  137<br />
to 0.</p>
<p>The discussion on the floor this morning clearly delineated  the protective<br />
intent of the bill. The bill will now proceed to the Senate  for<br />
consideration.</p>
<p>H.B. 6200 contains language that will protect CT  licensed Lyme treating<br />
physicians from prosecution by the State of  Connecticut Medical Examining<br />
Board solely on the basis of a clinical  diagnosis and /or for treatment of<br />
long-term Lyme disease.</p>
<p>The bill  provides the definition for Lyme disease which includes , &#8220;the<br />
presence in a  patient of signs and symptoms compatible with acute infection<br />
with Borrelia  burgdorferi; or with late stage or persistent or chronic<br />
infection with  Borrelia burgdorferi, or with complications related to such<br />
an infection.&#8221;</p>
<p>It also defines clinical diagnosis as determined by a physician &#8220;.that  is<br />
based on knowledge obtained through the medical history and  physical<br />
examination alone, or in conjunction with the testing that  provides<br />
supportive data for such clinical diagnosis.&#8221; In addition, it  provides for<br />
updating the definition if other strains are found to cause Lyme  disease.</p>
<p>The final bill was the result of months of negotiations between  Legislative<br />
leaders, the Connecticut Department of Public Health and the  undersigned<br />
groups representing patients.</p>
<p>We would like to thank  Representatives Jason Bartlett, Kim Fawcett, Chris<br />
Lyddy , Peggy Reeves and  all of the legislators who supported this bill.</p>
<p>We would also like to  thank the Legislative leadership for taking time from<br />
their busy schedules to  meet with us over the past several weeks. We<br />
particularly thank the joint  Public Health Committee Chairs, Representative<br />
Betsy Ritter and Senator  Jonathan Harris and the Public Health Committee for<br />
understanding this  complex issue and its importance to patients in CT.</p>
<p>We would like to  extend our appreciation to the patients, families and<br />
members of the Lyme  community who wrote letters, made phone calls and<br />
testified in support of  H.B. 6200.</p>
<p>We have confidence that the Connecticut Senate will fulfill  its commitment<br />
to CT residents and pass this important piece of legislation  intact.</p>
<p>Please note this bill has moved from the Public Health Committee; it  still<br />
needs to be passed by the House; Senate and Rell; but is big  step!</p>
<p>=========================</p>
<p><a title="blocked::http://www.newstimes.com/ci_12005818" href="http://www.newstimes.com/ci_12005818">http://www.newstimes.com/ci_12005818</a></p>
<p>Controversial  Lyme disease bill passed by legislative Public Health<br />
Committee<br />
By Brian  Lockhart<br />
Staff Writer<br />
Updated: 03/26/2009 11:03:49 PM EDT</p>
<p>HARTFORD  &#8212; The Legislature&#8217;s Public Health Committee unanimously passed a<br />
bill  about tick-borne Lyme disease Thursday that could rock the health  care<br />
industry if it becomes law.</p>
<p>&#8220;This is a huge message,&#8221; state Rep.  Kim Fawcett, D-Fairfield, the bill&#8217;s<br />
sponsor, said after the panel approved  the proposal without debate.</p>
<p>The proposal would validate the treatment of  chronic Lyme disease in<br />
Connecticut. It clarifies to physicians, despite an  opinion from the<br />
Infectious Disease Society of America that chronic Lyme  disease does not<br />
exist, that they do have the right to diagnose and prescribe  long-term<br />
antibiotics for the illness without fear of reprisal by the  state.</p>
<p>&#8220;The thing that&#8217;s important to us is we send a clear message,  &#8216;It&#8217;s OK to go<br />
outside the Infectious Disease Society of America  guidelines,&#8217;&#8221; said<br />
Fawcett, who is not a member of the health  panel.</p>
<p>Discovered in the mid-1970s in Connecticut, Lyme disease is  transmitted to<br />
humans by the bite of infected blacklegged  ticks.</p>
<p>Symptoms include fever, headache, fatigue and a rash. If  untreated,<br />
infection can spread to joints, the heart and the nervous  system.</p>
<p>The commonly accepted treatment is up to 28 days of antibiotics.  But some<br />
patients are convinced they suffer from chronic Lyme disease and  need longer<br />
courses of antibiotic treatment.</p>
<p>But the Infectious  Diseases Society, which in 2006 developed updated<br />
treatment guidelines for  doctors, dismisses chronic Lyme disease as<br />
Advertisement<br />
a  myth.</p>
<p>&#8220;There are no convincing published scientific data that support  the<br />
existence of chronic Lyme disease,&#8221; Anne Gershon, president of  the<br />
Virginia-based society, wrote lawmakers in February.</p>
<p>She wrote  that the concept of chronic Lyme disease has been promoted by &#8220;a<br />
small group  of physicians&#8221; but the dangers of long-term antibiotic therapy<br />
are  well-documented and should not be encouraged by legislation like the<br />
bill  passed by the committee Thursday.</p>
<p>State Rep. Jason Bartlett, D-Bethel,  another bill sponsor who sits on the<br />
Public Health Committee, told colleagues  Thursday the legislation would<br />
address the dueling &#8220;standards for practice&#8221;  that have arisen over chronic<br />
Lyme disease.</p>
<p>&#8220;Because of these two  disagreements the (Connecticut) Department of Public<br />
Health, we feel, has  been biased towards the 28 days of antibiotics,&#8221;<br />
Bartlett  said.</p>
<p>He said the result is a &#8220;chill effect&#8221; on physicians who might  otherwise be<br />
willing to diagnose and treat chronic Lyme  disease.</p>
<p>Following a public hearing on the bill in early February,  William Gerrish, a<br />
spokesman for the health department, said there is no  state policy against<br />
long-term antibiotic treatment of Lyme  disease.</p>
<p>Gerrish said state health officials are concerned the bill as  written would<br />
strip the department of its ability to review complaints and  violations,<br />
particularly in cases where the care being provided to a patient  deviates<br />
from current, evidence-based practice.</p>
<p>No doctors offered  testimony in February that they felt persecuted by the<br />
state health  department for treating chronic Lyme disease.</p>
<p>But at the time, Matthew  Katz, vice president of the Connecticut State<br />
Medical Society, confirmed  there are concerns among physicians over the<br />
state&#8217;s recent actions against  Dr. Charles Ray Jones, a New Haven<br />
pediatrician renowned for treating chronic  Lyme disease.</p>
<p>In December 2007, the state Medical Examining Board,  responding to an<br />
investigation by the Department of Public Health, fined  Jones $10,000 and<br />
put him on probation for two years for diagnosing children  with Lyme disease<br />
and treating them with antibiotics before examining  them.</p>
<p>Jones is appealing the decision.</p>
<p>Katz said news coverage  focused on the doctor&#8217;s reputation as a last resort<br />
for those complaining of  chronic Lyme disease.</p>
<p>&#8220;What appeared in the paper and on the news &#8212; Lyme  disease mistreatment &#8211;<br />
it raised a lot of concerns,&#8221; Katz said at the  time.</p>
<p>Fawcett&#8217;s bill states that as of July 1, 2009, the Medical  Examining Board<br />
may not discipline a licensed physician &#8220;solely for&#8221;  prescribing,<br />
administering and dispensing long-term antibiotic therapy to a  patient<br />
clinically diagnosed with Lyme disease as documented in their  medical<br />
records.</p>
<p>The State Medical Society backs the concept of the  bill, but is not taking a<br />
position on the existence of chronic Lyme  disease.</p>
<p>Gerrish said the Department of Public Health is still hoping to  work with<br />
the health committee to &#8220;preserve our ability to conduct a  thorough<br />
investigation to protect the public.&#8221;</p>
<p>&#8220;That bill is perfect  in our eyes,&#8221; Fawcett said.</p>
<p>But Health Committee co-chairwoman state Rep.  Betsy Ritter, D-Quaker Hill,<br />
told her colleagues before Thursday&#8217;s vote the  legislation may change before<br />
going to the full General  Assembly.</p>
<p>&#8220;There will be &#8220;at least a bit more work going on with this  bill before<br />
we&#8217;re finished,&#8221; Ritter said.</p>
<p>On 3/27/09 6:06 AM, &#8220;Maggie  Shaw&#8221; &lt;<a title="blocked::mailto:Lancaster60@aol.com" href="mailto:Lancaster60@aol.com">Lancaster60@aol.com</a>&gt; wrote:</p>
<p>Click  here: Controversial Lyme disease bill passed by legislative Public<br />
Health  Committee &#8211; NewsTimes.com &lt;<a title="blocked::http://www.newstimes.com/ci_12005818" href="http://www.newstimes.com/ci_12005818">http://www.newstimes.com/ci_12005818</a>&gt;</p>
<p>_____</p></div>
<div id="ygrp-grft" style="padding: 15px 0px; font-size: 77%; font-family: Verdana;">
<p>For more  information visit<br />
<a title="blocked::http://www.lymedisease.com/" href="http://www.lymedisease.com/">http://www.lymedisease.com</a><br />
<!-- |**|end egp html banner|**| --></div>
</div>
</div>
<p></span></div>
]]></content:encoded>
			<wfw:commentRss>http://www.cynthiamchase.com/publications-cynthia-chase-likes/428/lyme-in-the-news-good-news/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Healing Power of our Past-Dr. Norton Berkowitz and Dr. Hollie Martin</title>
		<link>http://www.cynthiamchase.com/publications-cynthia-chase-likes/244/the-healing-power-of-our-past-dr-norton-berkowitz-and-dr-hollie-martin</link>
		<comments>http://www.cynthiamchase.com/publications-cynthia-chase-likes/244/the-healing-power-of-our-past-dr-norton-berkowitz-and-dr-hollie-martin#comments</comments>
		<pubDate>Sun, 28 Dec 2008 22:42:15 +0000</pubDate>
		<dc:creator>Cynthia</dc:creator>
				<category><![CDATA[Interesting Publications]]></category>
		<category><![CDATA[past lives]]></category>

		<guid isPermaLink="false">http://www.cynthiamchase.com/?p=244</guid>
		<description><![CDATA[The Healing Power of our Past-  I wrote a portion of a chapter in this book called “The Process Unveiled” revealing the use of hypnotherapy in uncovering the past; the chapter discusses how a specifically designed hypnosis protocol helps the client re-experience past trauma, then releases that pain in a method called “Guided Light Therapy”: (developed [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNormal"><strong>The Healing Power of our Past</strong>-  <span style="font-size: 10pt; font-family: Arial;"><span style="font-size: 10pt; font-family: Arial;">I wrote a portion of a chapter in this book called “The Process Unveiled” revealing the use of hypnotherapy in uncovering the past; the chapter discusses how a specifically designed hypnosis protocol helps the client re-experience past trauma, then releases that pain in a method called “Guided Light Therapy”: (developed by Dr. Norton Berkowitz). </span></span></p>
<p class="MsoNormal"><span style="font-size: x-small; font-family: Arial;"><span style="font-size: 10pt; font-family: Arial;">Excerpts follow:</span></span></p>
<p class="MsoNormal"><span style="font-size: x-small; font-family: Arial;"><span style="font-size: 10pt; font-family: Arial;">“I decided to enter into training with Norton, both as an adventure and as an exploration into these fantastic possibilities of understanding ourselves more deeply, and to determine the usefulness of these approaches in healing, especially for psychoanalytical use.  My learning goal was both personal and professional.  Although the techniques of Life Memory Recall and Guided Light Therapy sounded easily reproducible, I knew they were not and I knew I needed guidance to learn them.  These techniques developed out of years of experience and as a culmination of information Norton retrieved from working with Hollie.  … Since that time I have hypnotized many of my patients.  I have seen them speak in foreign languages, some of the languages reputedly long lost in history. I have heard endless adventures, sagas, traumas relived.  I have seen incredible remissions of long-standing symptoms in my patients that the traditional methods of psychotherapy were unable to affect. I have seen terrible pain and suffering released, allowing the patient to go on free of his or her burdens.”</span></span></p>
<p class="MsoNormal"><span style="font-size: x-small; font-family: Arial;"><span style="font-size: 10pt; font-family: Arial;"> <span style="font-size: 10pt; font-family: Arial;">“The Healing Power of our Past” by Dr. Norton Berkowitz and Dr. Hollie Martin. Published by iUniverse, Inc, New York Lincoln Shanghai, Copyright 2005</span></span></span></p>
<p class="MsoNormal"><span style="font-size: x-small; font-family: Arial;"><span style="font-size: 10pt; font-family: Arial;"><span style="font-size: 10pt; font-family: Arial;">Want to buy it?    Amazon link:   <a href="http://www.amazon.com/Healing-Power-Our-Past/dp/0595349242/" target="_blank">The Healing Power of our Past</a></span></span></span></p>
]]></content:encoded>
			<wfw:commentRss>http://www.cynthiamchase.com/publications-cynthia-chase-likes/244/the-healing-power-of-our-past-dr-norton-berkowitz-and-dr-hollie-martin/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
